These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4790575)

  • 21. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
    Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
    Kosmidis J; Hamilton-Miller JM; Gilchrist JN; Kerry DW; Brumfitt W
    Br Med J; 1973 Dec; 4(5893):653-5. PubMed ID: 4202265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of BL-S217, a new cephalosporin antibiotic.
    Casey F; Bodey GP
    J Antibiot (Tokyo); 1974 Jul; 27(7):520-4. PubMed ID: 4156357
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative inhibitory activity of BL-S640 and two other cephalosporins.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    J Antibiot (Tokyo); 1975 Aug; 28(8):590-3. PubMed ID: 239917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins.
    Vuye A; Pijck J; Soep H
    Antimicrob Agents Chemother; 1976 Mar; 9(3):422-32. PubMed ID: 1259401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.
    Ripa S; Prenna M
    Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory evaluation of FR10024 a new cephalosporin derivative.
    Nishida M; Murakawa T; Kamimura T; Okada N; Fukada S
    Antimicrob Agents Chemother; 1977 Jan; 11(1):51-63. PubMed ID: 836014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
    Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cefazedone with cefazolin and cephalothin in treatment of experimental infections in mice.
    Bergmann R; Wahlig H; Mitsuhashi S
    Arzneimittelforschung; 1979; 29(2a):412-4. PubMed ID: 582716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
    Kim MY; Oh JI; Paek KS; Kim YZ; Kim IC; Kwak JH
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1825-31. PubMed ID: 8843288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.
    Actor P; Uri JV; Guarini JR; Zajac I; Phillips L; Sachs CS; DeMarinis RM; Hoover JR; Weisbach JA
    J Antibiot (Tokyo); 1975 Jun; 28(6):471-6. PubMed ID: 238925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.
    Heymès R; Lutz A; Schrinner E
    Infection; 1977; 5(4):259-60. PubMed ID: 413795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
    Mitsukude M; Inoue M; Mitsuhashi S
    Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.
    Nishida M; Kamimura T; Okada N; Matsumoto Y; Mine Y; Murakawa T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1979 Dec; 32(12):1319-27. PubMed ID: 317284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.